Evidence map›Paper›PMID 23397255›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2013

International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests.

D Creely, G Zambardi, A van Belkum, Wm M Dunne, M Peyret, J P Gayral, D Shortridge, C Shubert

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Validation of Three MicroScanDiagnostics (Basel, Switzerland) · 2022
    Article
  3. Review
  4. Piperacillin-Tazobactam (TZP) Resistance inFrontiers in microbiology · 2019
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

D CreelybioMérieux Inc., 595 Anglum Rd., Hazelwood, St. Louis, MO, USA.
G Zambardi
A van Belkum
Wm M Dunne
M Peyret
J P Gayral
D Shortridge
C Shubert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preventing the dissemination of antimicrobial resistance depends on appropriate antibiotic stewardship and accurate antimicrobial susceptibility testing (AST). We report the international dissemination of Escherichia coli strains, showing discrepancies between reference methods when phenotypically tested for susceptibility to piperacillin/tazobactam (TZP). We demonstrate that these related strains are predisposed to problematic TZP AST interpretations.

Indexed as

Anti-Bacterial AgentsCluster AnalysisDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsHumansMicrobial Sensitivity TestsPenicillanic AcidPhenotypePiperacillinPiperacillin, Tazobactam Drug CombinationReference StandardsReproducibility of ResultsAnti-Bacterial AgentsPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug Combination

Identifiers

PMID23397255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.